Immediate Impact
36 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Works of Beiying Dai being referenced
Reinvigorating exhausted CD8+ cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Beiying Dai | 68 | 49 | 32 | 50 | 9 | 150 | |
| Rachael B. Rowswell-Turner | 69 | 46 | 19 | 113 | 14 | 213 | |
| Giuseppe Mallel | 80 | 47 | 19 | 23 | 12 | 172 | |
| Dan-Arin Silasi | 79 | 44 | 21 | 19 | 7 | 183 | |
| Phuong Dinh | 84 | 56 | 22 | 11 | 8 | 162 | |
| Shuping Ding | 101 | 54 | 11 | 74 | 7 | 169 | |
| Jean-Pierre David | 52 | 94 | 13 | 27 | 9 | 175 | |
| Hiroki Kamata | 76 | 45 | 5 | 26 | 10 | 166 | |
| Assia Ifticene‐Treboux | 124 | 82 | 15 | 51 | 8 | 210 | |
| R Blandino | 64 | 80 | 8 | 46 | 9 | 207 | |
| Devora Delman | 65 | 86 | 15 | 36 | 8 | 172 |
All Works
Login with ORCID to disown or claim papers
Loading papers...